- This event has passed.
Life Sciences Dealmaking Symposium 2020
November 17, 2020
In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to bringing innovations to market.
Join us virtually for our signature Life Sciences Dealmaking Symposium, where seasoned dealmakers, industry executives and technical experts come together with McDermott’s leading life sciences lawyers. Beginning October 20, we’ll bring you a series of three pre-Symposium programs focused on today’s most pressing concerns for life sciences dealmakers, all culminating in a half-day virtual program with multiple networking sessions, industry-leading keynote speakers and insights from investors, life sciences executives, policy experts and investment bankers.
SCOTT GOTTLIEB, M.D.
Immediate Past Commissioner Food and Drug Administration (2017-2019); Former Senior Advisor – CMS
DR. MICHELLE MCMURRY-HEATH
President & CEO, Biotechnology Innovation Organization
- November 17, 2020